Critical care medicine
-
Critical care medicine · Nov 2011
Randomized Controlled Trial Multicenter StudyEffect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study.
To investigate whether the use of pravastatin reduces the frequency of ventilator-associated pneumonia and whether it is related to favorable outcomes in critical care patients. ⋯ This study provides evidence that pravastatin may favorably affect the outcome of critical care patients.